Stachyose

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Stachyose.

Stachyose is a non-reducing tetrasaccharide prebiotic that selectively modulates the gut microbiome by promoting the proliferation of Bifidobacterium and Lactobacillus species, thereby enhancing the production of short-chain fatty acids and improving intestinal barrier function.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

439531

Molecular Weight

666.6 g/mol

XLogP3 (Lipophilicity)

-8

IUPAC Name

(2S,3R,4S,5R,6R)-2-[[(2R,3R,4S,5R,6S)-6-[[(2R,3S,4S,5R,6R)-6-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

Bifidobacterium animalis for synergistic synbiotic colonization and metabolic byproduct production
Inulin for sequential fermentation across distinct segments of the gastrointestinal tract

Biological Formulation Enhancers

Resistant Starch for protection against premature enzymatic hydrolysis in the upper gastrointestinal tract
Enteric Coating for site-specific delivery to the distal ileum and colon to maximize prebiotic efficacy

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Stachyose across standard consumer modalities.

💊 Standard Capsules

The hygroscopic nature of stachyose necessitates the use of HPMC capsules and moisture-barrier packaging to prevent powder caking and maintain stability.

🍬 Gummy & Pectin Formats

Incorporating effective prebiotic dosages of stachyose into pectin matrices is limited by the high mass required, which can compromise the structural integrity and chewability of the gummy.

🔬 Thin-Film Oral Strips

The high therapeutic dose required for stachyose exceeds the physical payload capacity of thin-film polymers, making oral strips an unsuitable delivery vehicle.

For Brand Founders

Formulate with Stachyose

Ready to launch a product featuring Stachyose? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Stachyose Bioavailability

Need absolute proof that your Stachyose extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Stachyose Degradation Testing

Is your Stachyose payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation